Live

Watch: Treasury Secretary Bessent testifies before House committee

Tokyo - Delayed Quote JPY

Matsui Construction Co., Ltd. (1810.T)

955.00

+2.00

+(0.21%)

At close: May 2 at 3:30:00 PM GMT+9

AMD earnings preview, Datadog, Ferrari profits: Trending Tickers

Catalysts host Madison Mills and Strategas Research Partners head of technical & macro research Chris Verrone examine some of Tuesday morning's trending tickers. Advanced Micro Devices (AMD) is in focus ahead of the company's first quarter earnings results, which will be released after the closing bell on Tuesday. The chipmaker's results and guidance could offer insight into the greater artificial intelligence (AI) landscape. Datadog (DDOG) topped first quarter earnings estimates and lifted its second quarter guidance. Ferrari (RACE) reported a 15% year-over-year profit increase in its first quarter, though the company emphasized that tariffs could impact its profitability going forward. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Video 10 minutes ago

DDOG

AMD

RACE
DoorDash buys SevenRooms, Constellation Energy, Marriott outlook

DoorDash (DASH) will acquire SevenRooms in a $1.2 billion deal, while the delivery app also announced its purchase of Deliveroo (ROO.L). Constellation Energy (CEG) fell shy of first quarter profit estimates. The energy company is maintaining its full-year outlook. Marriott International (MAR) lowers its full-year guidance, the latest hotel operator to report uncertainties tied to global trade wars and tariffs. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 58 minutes ago

H

DLVEY

DROOF
Ford warns on tariffs, Palantir slides, Fed meeting: 3 Things

Following its latest earnings beat, US automaker Ford (F) warned of the trade war impacts that President Trump's could have on the company and the broader auto industry. Palantir Technologies (PLTR) topped first quarter revenue estimates after reporting results on Monday. The company's shares are falling in Tuesday's pre-market trading. Federal Reserve officials are convening in Washington, D.C. for their May FOMC meeting starting today and concluding on Wednesday, May 7, with the latest decision on interest rates and a press conference with Chair Jerome Powell. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 1 hour ago

ES=F

PLTR

NQ=F
Hims & Hers stock slips on disappointing Q2 revenue outlook

Shares of Hims & Hers Health traded slightly lower in after-hours trading. The company reported first quarter revenue of $586.0 million compared to the expected $538.2 million. Wall Street is likely disappointed in the second quarter revenue forecast of $530 million to $550 million. Analysts had been expecting $563.9 million. Market Domination Overtime Anchors Julie Hyman and Josh Lipton are joined by Senior Healthcare Reporter Anjalee Khemlani to discuss the results. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 18 hours ago

HIMS
Ford, US automakers take in Trump's auto part tariff relief

American automakers — including the Big Three, comprised of Ford (F), General Motors (GM), and Stellantis (STLA) — continue to digest the Trump administration's tariffs policies on foreign-made auto parts. President Trump has allowed partial exemptions on these US auto companies. Ford is scheduled to publish first quarter earnings after Monday's market close. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 18 hours ago

RIVN

TSLA

F
Buffett succession, Palantir earnings preview, Hims COO pick

At Berkshire Hathaway's (BRK-B, BRK-A) annual shareholders meeting over the weekend, chairman and CEO Warren Buffett, 94, announced that he will step down and be succeeded by Berkshire Hathaway Energy Chair Greg Abel at the end of the year. Palantir (PLTR) is set to publish its first quarter earnings after Monday's market close. Hims & Hers Health (HIMS) announced that former Amazon (AMZN) executive Nader Kabbani will be joining the telehealth company as its new COO. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Video 23 hours ago

PLTR

BRK-B

HIMS
Stock Market Today: Dow Jones, S&P 500 Extend Monday's Losses; Palantir Plummets After Earnings (Live Coverage)

The Dow Jones and the major indexes sank Tuesday morning. Palantir stock plunged on the stock market today after the earnings report.

Investor's Business Daily 4 minutes ago

HIMS

DASH

PLTR
Vertex Pharmaceuticals Stock Sinks as Costs Soar

Vertex Pharmaceuticals missed first-quarter profit and revenue forecasts as costs jumped.

Investopedia 18 minutes ago

VRTX
Ford Suspended Its Earnings Guidance. Why the Stock Is Rising.

Ford Motor reported far better-than-expected first-quarter results but sees a steep hit to profits for the full year and has suspended its financial guidance. “Our fundamental business is improving,” said Sherry House, chief financial officer, during a call with reporters. Ford stock opened in the red but recovered.

Barrons.com 18 minutes ago

F
Why Palantir Stock Is Plummeting Today

Palantir stock is sinking despite strong quarterly results posted yesterday. Palantir's business looks very impressive, but the company's highly growth-dependent valuation sets the stage for volatility. Palantir (NASDAQ: PLTR) stock is getting hit with big sell-offs in Tuesday's trading after the company's first-quarter earnings release yesterday.

Motley Fool 23 minutes ago

PLTR
Palantir Stock Crashes After Earnings but It Could Still Soar 300%, According to a Wall Street Analyst

Palantir stock crashed after the company reported its first-quarter financial results. Management highlighted continued demand for its artificial intelligence platform, AIP. Dan Ives at Wedbush says Palantir will be a trillion-dollar company in two or three years.

Motley Fool 24 minutes ago

PLTR
Tesla Sales Fell 46% in Germany. That’s Just the Latest Bad News for the Stock.

As car makers, including Tesla, report first quarter results. The impact of tariffs has become clearer.

Barrons.com 26 minutes ago

TSLA

F

RIVN
Palantir CEO Alex Karp Ends Plan to Sell Stock

Palantir Technologies CEO Alex Karp canceled a plan to sell stock when the share price swooned. The data-analytics firm said that on March 10, Karp terminated a so-called Rule 10b5-1 trading plan that provided for the sale of 9,975,000 shares through Sept. 12. The company disclosed Karp’s action in a form it filed with the Securities and Exchange Commission Monday night.

Barrons.com 29 minutes ago

PLTR
Why Vertex Pharmaceuticals Stock Is Sinking Today

Vertex Pharmaceuticals reported disappointing Q1 revenue and earnings. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. Vertex reported Q1 revenue of $2.77 billion, up 3% year over year.

Motley Fool 30 minutes ago

VRTX
Palantir Slides by Most in a Year as Sales Forecast Falls Short

(Bloomberg) -- Palantir Technologies Inc. shares slid by the most in nearly a year after its financial results and projections failed to live up to investors’ lofty expectations.Most Read from BloombergThe Battle Over the Fate of Detroit’s Renaissance CenterNYC Real Estate Industry Asks Judge to Block New Broker Fee LawNJ Transit Strike Would Be ‘Disaster’ for Region, Sherrill SaysIceland Plans for a More Volcanic FutureVail to Borrow Muni Debt to Ease Ski Resort Town Housing CrunchThe company d

Bloomberg 31 minutes ago

PLTR
Palantir Soars in Tech Talk, Shares Slip Premarket

Analysts hail generational AI name as blowout results clash with stretched multiples

GuruFocus.com 35 minutes ago

PLTR
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks

Vertex stock skidded Tuesday on a series of first-quarter setbacks that included light sales, slow uptake for two drugs and a paused study.

Investor's Business Daily 35 minutes ago

VRTX
Why Palantir Stock Is Crashing Today

Palantir released its Q1 2025 earnings after the market closed Monday. The company's valuation is incredibly high, and doesn't give Palantir any room for error. Shares of Palantir Technologies (NASDAQ: PLTR) are falling on Tuesday.

Motley Fool 39 minutes ago

PLTR
Marriott Trims Outlook on 'Softer' U.S. Demand But Sees Strength Internationally

Marriott's revised outlook for 2025 has one overriding theme: Executives believe that U.S. and international travel spending could stay fairly resilient this year despite the shocks of the tariff war.

Skift 45 minutes ago

MAR
SolarEdge Stock Stands Out on Tariffs as Earnings Surprise Street

The solar company reported a first-quarter adjusted loss of $1.14 a share, on revenue of $219.5 million.

Barrons.com 46 minutes ago

SEDG

Performance Overview

Return	1810.T	Nikkei 225 (^N225)
YTD	+8.55%	-7.68%
1-Year	+17.11%	-3.68%
3-Year	+62.68%	+37.33%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

Matsui Construction Co., Ltd. (1810.T)

Related News

AMD earnings preview, Datadog, Ferrari profits: Trending Tickers

DoorDash buys SevenRooms, Constellation Energy, Marriott outlook

Ford warns on tariffs, Palantir slides, Fed meeting: 3 Things

Hims & Hers stock slips on disappointing Q2 revenue outlook

Ford, US automakers take in Trump's auto part tariff relief

Buffett succession, Palantir earnings preview, Hims COO pick

Stock Market Today: Dow Jones, S&P 500 Extend Monday's Losses; Palantir Plummets After Earnings (Live Coverage)

Vertex Pharmaceuticals Stock Sinks as Costs Soar

Ford Suspended Its Earnings Guidance. Why the Stock Is Rising.

Why Palantir Stock Is Plummeting Today

Palantir Stock Crashes After Earnings but It Could Still Soar 300%, According to a Wall Street Analyst

Tesla Sales Fell 46% in Germany. That’s Just the Latest Bad News for the Stock.

Palantir CEO Alex Karp Ends Plan to Sell Stock

Why Vertex Pharmaceuticals Stock Is Sinking Today

Palantir Slides by Most in a Year as Sales Forecast Falls Short

Palantir Soars in Tech Talk, Shares Slip Premarket

Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks

Why Palantir Stock Is Crashing Today

Marriott Trims Outlook on 'Softer' U.S. Demand But Sees Strength Internationally

SolarEdge Stock Stands Out on Tariffs as Earnings Surprise Street

Performance Overview